![](/img/cover-not-exists.png)
P002 Interleukin-8 (IL8) and transforming growth-factor beta (TGF-β) as drugable biomarkers of response, progression-free (PFS) and overall survival (OS) with pazopanib (PZP): A phase 2 study in relapsed urothelial cancer (UC)
Necchi, A., Mariani, L., Zaffaroni, N., Giannatempo, P., Nicolai, N., Raggi, D., Pennati, M., Morosi, C., Lanocita, R., Crippa, F., Daidone, M.G., Gianni, A.M., De Braud, F., Salvioni, R.Volume:
11
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(13)60383-8
Date:
November, 2012
File:
PDF, 106 KB
english, 2012